SCHEMBL7325713

SCHEMBL7325713

CN(C)C(=O)C1(C(=O)c2ccc(Cl)cc2)CC[N]CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 1/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 2/20 0.38
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.36
MAPT P10636 1/20 0.36
ALOX12 P18054 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 2/20 0.36
POLB P06746 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
HTT P42858 1/20 0.35
P2RX7 Q99572 1/20 0.35
CES2 O00748 2/20 0.35
CES1 P23141 2/20 0.35
TSHR P16473 2/20 0.35
ALOX15 P16050 1/20 0.34
CCR2 P41597 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7325717 0.82 DRD2 (0.41) DRD3HPGDCYP1A2MAPTALOX12
SCHEMBL7327181 0.76 ALDH1A1 (0.36) HPGDMAPTCYP2C19ALDH1A1P2RX7
SCHEMBL7327175 0.76 ALDH1A1 (0.36) HPGDMAPTCYP2C19ALDH1A1P2RX7
SCHEMBL4674963 0.74 CES2 (0.42) RAB9ANPC1HPGDMAPTALDH1A1
SCHEMBL7327084 0.74 MAPT (0.38) RAB9ANPC1HPGDCYP1A2MAPT
SCHEMBL7316370 0.73 GAA (0.42) HPGDCYP1A2CYP2C19ALDH1A1P2RX7
SCHEMBL28626237 0.69 TSHR (0.50) HPGDMAPTALDH1A1CES2CES1
SCHEMBL9628068 0.67 CES2 (0.48) DRD3HPGDMAPTALDH1A1POLB
SCHEMBL3520379 0.66 HSD11B1 (0.58) DRD3ALDH1A1HSD11B1
SCHEMBL11303491 0.65 HDAC4 (0.47) MAPTALDH1A1CES2CES1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed
US-6143744-A Sulfamide-metalloprotease inhibitors SYNTEX (U.S.A.) INC. (US) 2000-11-07 US disclosed
US-6130220-A ENZYME INHIBITORS SYNTEX (USA) INC. (US) 2000-10-10 US disclosed